Cost Savings for MDDAP appraisals over typical compliance audits by FDA

“Edwards Lifesciences is among the companies participating in the pilot program, and Rob Becker, director of quality at Edwards, said the MDDA audit that the company went through in 2017 ended up costing Edwards about $74,000 compared to a traditional compliance audit that would have cost closer to $140,000. What’s more, Becker said the process involved minimal business interruption compared to what the company was used to dealing with in the compliance audit process.” https://www.mddionline.com/what-if-fda-and-medtech-worked-together-quality […]

FDA wants to create a Center of Excellence on Digital Health

FDA Commissioner Scott Gottlieb (@SGottliebFDA) wants to create a Center of Excellence on Digital Health “to establish the regulatory paradigm, build new capacity to evaluate and recognize third-party certifiers, and support a cybersecurity unit to complement the advances in software-based devices. To modernize and expand its existing capabilities to ensure the cybersecurity of medical devices, the FDA would enhance its ability to coordinate device-specific responses to cybersecurity vulnerabilities and incidents. The FDA also would implement […]

MDICx – Quarterly update on the CDRH Case for Quality Voluntary Medical Device Manufacturing and Product Quality Pilot Program February 27, 2018 – 12 p.m. eastern

Interested in the Medical Device Discovery Appraisal Program (#mddap) and how it uses @CMMI_Institute framework to help medical device companies and get regulatory modifications from the @FDAcdrhIndustry? Attend the next CfQ webinar Feb 27: http://mdic.org/mdicx/ In 2017, CDRH launched a pilot project designed to incentivize medical device manufacturers to demonstrate mature quality practices by reducing certain regulatory requirements for those who demonstrate quality maturity (http://mdic.org/cfq/enroll/). CDRH expects the pilot to continue through 2018 and MDIC […]

Interview with Cisco Vicenty regarding the Case for Quality

Just over an hour long, Dan Matlis sat down with the Program Manager for the Case for Quality, Cisco Vicenty to discuss the goals and state of the program.  https://www.youtube.com/watch?v=Z4BLB3yZuGw.  Cisco discusses the objectives of the CfQ, what FDA have been learning from the program and the CMMI Medical Device Discovery Appraisal Program (MDDAP).

Industry comments positively on the Digital Health Precertification Program

“When it comes to digital health, the FDA has leapfrogged industry” and  “Industry adherence to slow-moving, old-school regulations and guidance documents has had terrible unintended consequences that have been detrimental to public health.” Wow.  Incredible read written by one of the participants in the Digital Health Precert program: https://tidepool.org/fda-precert-site-visit-recap/ 

FDA announces “Fostering Medical Innovation: Case for Quality Voluntary Medical Device Manufacturing and Product Quality Pilot Program”

FDA has announced “Fostering Medical Innovation: Case for Quality Voluntary Medical Device Manufacturing and Product Quality Pilot Program” at https://www.federalregister.gov/documents/2017/12/28/2017-28044/fostering-medical-innovation-case-for-quality-voluntary-medical-device-manufacturing-and-product – contact us at Two Harbors for details. “Through collaboration with the Medical Device Innovation Consortium (MDIC) over the last 2 years, a maturity model and appraisal system (i.e., Capability Maturity Model Integration (CMMI) system) that can be adapted for the medical device industry was selected for this CfQ Pilot Program. The CMMI system is a […]

Recent FDA announcements to modernize

The FDA’s commissioner Scott Gottlieb made several large announcements this week that reflect a continued drive to reduce regulatory burden to industry to foster an environment for innovation and allowing greater speed to market for regulated products. Earlier in the week the Agency announced its intentions to publish a guidance to “modernize” the 510(k) process:  “FDA intends to publish a draft guidance, again in early 2018, setting forth factors that the agency may consider when assessing […]